Nikolaos S. Salemis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nikolaos S. Salemis has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
Stavros Gourgiotis
First Department of Surgery, 417 NIMTS Veterans' Fund Hospital, Athens, Greece
13 shared publicationsEfstathios Tsohataridis
Army Veterans General Hospital
11 shared publicationsGeorgios Nakos
Department of Pathology Army General Hospital Athens Greece
9 shared publicationsEvangelos Tsiambas
Department of Pathology, Army General Hospital, Athens, Greece
8 shared publications- Stavros Gourgiotis
First Surgical Department, 417 NIMTS Military Veterans' Fund Hospital of Athens, Greece
7 shared publications Andreas Karameris
Army Veterans General Hospital
5 shared publications
Latest Publications
- Open Access
- 30 December 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (1) , 238
Concomitant Valve Replacement and Coronary Artery Bypass Grafting Surgery: Lessons from the Past, Guidance for the Future? A Mortality Analysis in 294 Patients
Objective: The aims of this study were to analyze parameters influencing early and late mortality after concomitant valve replacement and coronary artery bypass grafting surgery, using early and long-term information from an institutionally available data registry, and to discuss the results in relation to the current treatment strategies and perspectives. Methods: The study population consisted of 294 patients after combined valve replacement with mechanical prosthesis and CABG surgery. Results: There were 201 men (68.4%) and 93 women (31.6%). Concurrent to the coronary artery bypass grafting, 238 patients (80.9%) underwent aortic-, 46 patients (15.6%) mitral- and 10 patients (3.4%) doublevalve replacement. Cumulative duration of follow up was 1007 patient-years (py) with a maximum of 94 months and was completed in 92.2% (271 cases). Overall hospital mortality (30 days) rate was 6.5% (n = 19). It was significantly higher in patients of female gender, older than 70 y, in those suffering preoperative myocardial infarction, presenting with an additive EuroScore > 8 and being hemodynamically unstable after the operation. Cumulative survival rate at 7.6 y was 78.6%. Determinants of prolonged survival were male gender, age at operation < 70 y, preoperative sinus rhythm, normal renal function, additive EuroScore < 8 and the use of internal thoracic artery for grafting. Subsequent multivariate analysis revealed preoperative atrial fibrillation (HR: 2.1, 95% CI: 0.82–5.44, p: 0.01) and risk group of ES > 8 (HR: 3.63, 95% CI: 1.45–9.07, p < 0.01) as independent predictors for lower long-term survival. Conclusions: Hospital mortality (30 d) was nearly 2.5-fold higher in female and/or older than 70 y patients. Preoperative atrial fibrillation and/ or a calculated ES > 8 were independent predisposing factors of late mortality for combined VR and CABG surgery. Tailoring the approach, with the employment of the newest techniques and hybrid procedures, to the individual patient clinical profile enables favorable outcomes for concomitant valvular disease and CAD, especially in high-risk patients.
- 30 December 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (1) , 238
Open AccessConcomitant Valve Replacement and Coronary Artery Bypass Grafting Surgery: Lessons from the Past, Guidance for the Future? A Mortality Analysis in 294 Patients
Objective: The aims of this study were to analyze parameters influencing early and late mortality after concomitant valve replacement and coronary artery bypass grafting surgery, using early and long-term information from an institutionally available data registry, and to discuss the results in relation to the current treatment strategies and perspectives. Methods: The study population consisted of 294 patients after combined valve replacement with mechanical prosthesis and CABG surgery. Results: There were 201 men (68.4%) and 93 women (31.6%). Concurrent to the coronary artery bypass grafting, 238 patients (80.9%) underwent aortic-, 46 patients (15.6%) mitral- and 10 patients (3.4%) doublevalve replacement. Cumulative duration of follow up was 1007 patient-years (py) with a maximum of 94 months and was completed in 92.2% (271 cases). Overall hospital mortality (30 days) rate was 6.5% (n = 19). It was significantly higher in patients of female gender, older than 70 y, in those suffering preoperative myocardial infarction, presenting with an additive EuroScore > 8 and being hemodynamically unstable after the operation. Cumulative survival rate at 7.6 y was 78.6%. Determinants of prolonged survival were male gender, age at operation < 70 y, preoperative sinus rhythm, normal renal function, additive EuroScore < 8 and the use of internal thoracic artery for grafting. Subsequent multivariate analysis revealed preoperative atrial fibrillation (HR: 2.1, 95% CI: 0.82–5.44, p: 0.01) and risk group of ES > 8 (HR: 3.63, 95% CI: 1.45–9.07, p < 0.01) as independent predictors for lower long-term survival. Conclusions: Hospital mortality (30 d) was nearly 2.5-fold higher in female and/or older than 70 y patients. Preoperative atrial fibrillation and/ or a calculated ES > 8 were independent predisposing factors of late mortality for combined VR and CABG surgery. Tailoring the approach, with the employment of the newest techniques and hybrid procedures, to the individual patient clinical profile enables favorable outcomes for concomitant valvular disease and CAD, especially in high-risk patients.
- 2 October 2022
- Published by Morressier GmbH
SENTINEL NODE RE-MAPPING IN PATIENTS WITH A SECOND PRIMARY BREAST CANCER AND PREVIOUS AXILLARY LYMPH NODE DISSECTION (ALND)
SENTINEL NODE RE-MAPPING IN PATIENTS WITH A SECOND PRIMARY BREAST CANCER AND PREVIOUS AXILLARY LYMPH NODE DISSECTION. Nikolaos S. Salemis MD, Ph. |
- 2 October 2022
- Published by Morressier GmbH
SENTINEL NODE RE-MAPPING IN PATIENTS WITH A SECOND PRIMARY BREAST CANCER AND PREVIOUS AXILLARY LYMPH NODE DISSECTION (ALND)
SENTINEL NODE RE-MAPPING IN PATIENTS WITH A SECOND PRIMARY BREAST CANCER AND PREVIOUS AXILLARY LYMPH NODE DISSECTION. Nikolaos S. Salemis MD, Ph. |
- 31 May 2021
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Intractable & Rare Diseases Research
- Vol. 10 (2) , 131-135
Synchronous occurrence of breast cancer and refractory diffuse large B-cell abdominal lymphoma: Management and review of the literature
The synchronous occurrence of primary breast cancer and lymphoid tissue malignant tumors has been rarely reported in the literature. We present an exceedingly rare case of synchronous breast invasive ductal carcinoma with an abdominal diffuse large B-cell lymphoma (DLBCL). A 78-yearold woman who was diagnosed with a luminal A invasive breast cancer on core biopsy, and complaint of progressively worsening low back pain. An abdominal computed tomography (CT) scan that was performed as part of the preoperative staging showed a large abdominal mass measuring 10.5 × 4.8 × 9.5 cm surrounding the lower part of the abdominal aorta, the right common iliac, right external, right internal iliac, and the left internal iliac arteries. A CT-guided fine-needle aspiration biopsy (FNAB) of the abdominal mass was then performed, to exclude the possibility of being an abdominal tumor metastasis of the known primary breast cancer. Histopathological findings were suggestive of DLBCL. Following a multidisciplinary team discussion, chemotherapy was initiated for DLBCL. The tumor however was refractory to multiple chemotherapy regimens and exhibited a highly aggressive clinical course. The diagnostic evaluation and management of the patient are discussed, along with a review of the relevant literature. This case underscores the fact that the presence of synchronous malignancies may pose both diagnostic and treatment challenges. Accurate staging of both malignancies and multidisciplinary team discussion is of utmost importance to guide an optimal therapeutic approach. Histopathological evaluation is essential for both tumors, for the second malignancy not to be misinterpreted as a secondary deposit of the primary one.
- 31 May 2021
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Intractable & Rare Diseases Research
- Vol. 10 (2) , 131-135
Synchronous occurrence of breast cancer and refractory diffuse large B-cell abdominal lymphoma: Management and review of the literature
The synchronous occurrence of primary breast cancer and lymphoid tissue malignant tumors has been rarely reported in the literature. We present an exceedingly rare case of synchronous breast invasive ductal carcinoma with an abdominal diffuse large B-cell lymphoma (DLBCL). A 78-yearold woman who was diagnosed with a luminal A invasive breast cancer on core biopsy, and complaint of progressively worsening low back pain. An abdominal computed tomography (CT) scan that was performed as part of the preoperative staging showed a large abdominal mass measuring 10.5 × 4.8 × 9.5 cm surrounding the lower part of the abdominal aorta, the right common iliac, right external, right internal iliac, and the left internal iliac arteries. A CT-guided fine-needle aspiration biopsy (FNAB) of the abdominal mass was then performed, to exclude the possibility of being an abdominal tumor metastasis of the known primary breast cancer. Histopathological findings were suggestive of DLBCL. Following a multidisciplinary team discussion, chemotherapy was initiated for DLBCL. The tumor however was refractory to multiple chemotherapy regimens and exhibited a highly aggressive clinical course. The diagnostic evaluation and management of the patient are discussed, along with a review of the relevant literature. This case underscores the fact that the presence of synchronous malignancies may pose both diagnostic and treatment challenges. Accurate staging of both malignancies and multidisciplinary team discussion is of utmost importance to guide an optimal therapeutic approach. Histopathological evaluation is essential for both tumors, for the second malignancy not to be misinterpreted as a secondary deposit of the primary one.
- 14 January 2021
- Published by Wiley in The Breast Journal
- Vol. 27 (3) , 280-283
Encapsulated papillary carcinoma of the breast
- 14 January 2021
- Published by Wiley in The Breast Journal
- Vol. 27 (3) , 280-283
Encapsulated papillary carcinoma of the breast
- 1 November 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (11) , 2248-2249
Subareolar male genital leiomyoma: An exceedingly rare clinical entity
Click on the article title to read more.
- 1 November 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (11) , 2248-2249
Subareolar male genital leiomyoma: An exceedingly rare clinical entity
Click on the article title to read more.
- 31 October 2020
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Intractable & Rare Diseases Research
- Vol. 9 (4) , 233-246
Primary neuroendocrine carcinoma of the breast: A rare presentation and review of the literature
Primary neuroendocrine carcinoma of the breast (NEBC) is a very rare occurrence accounting for less than 0.1% of all breast cancers. Typically, the tumor presents with ER- and PgR-positive and HER-2-negative status. Despite its luminal type, NEBC is associated with a more aggressive clinical course and poorer prognosis compared to the other types of invasive breast cancer. Clinical and radiological findings are nonspecific. The most common clinical manifestation is a palpable mass whereas in mammography the tumor most commonly appears as a round or oval mass without spiculated margins. Herein, a very rare case of NEBC is described in an asymptomatic patient who presented with an area of architectural distortion and the presence of microcalcifications that was incidentally detected on a screening mammography. A review of the literature has also been conducted. The diagnosis of NEBC requires a thorough investigation to exclude the possibility of a metastatic neuroendocrine tumor from another site because the two entities require different treatment approaches. Due to the rarity of the disease, the optimal therapeutic approach has not been clearly defined. Surgical resection is the mainstay of treatment. Further research is needed to better understand the molecular characteristics of NEBC and identify novel targeted therapies.
- 31 October 2020
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Intractable & Rare Diseases Research
- Vol. 9 (4) , 233-246
Primary neuroendocrine carcinoma of the breast: A rare presentation and review of the literature
Primary neuroendocrine carcinoma of the breast (NEBC) is a very rare occurrence accounting for less than 0.1% of all breast cancers. Typically, the tumor presents with ER- and PgR-positive and HER-2-negative status. Despite its luminal type, NEBC is associated with a more aggressive clinical course and poorer prognosis compared to the other types of invasive breast cancer. Clinical and radiological findings are nonspecific. The most common clinical manifestation is a palpable mass whereas in mammography the tumor most commonly appears as a round or oval mass without spiculated margins. Herein, a very rare case of NEBC is described in an asymptomatic patient who presented with an area of architectural distortion and the presence of microcalcifications that was incidentally detected on a screening mammography. A review of the literature has also been conducted. The diagnosis of NEBC requires a thorough investigation to exclude the possibility of a metastatic neuroendocrine tumor from another site because the two entities require different treatment approaches. Due to the rarity of the disease, the optimal therapeutic approach has not been clearly defined. Surgical resection is the mainstay of treatment. Further research is needed to better understand the molecular characteristics of NEBC and identify novel targeted therapies.
- 21 October 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (12) , 2409-2411
Metastatic brachial plexopathy as the initial manifestation of breast cancer
Click on the article title to read more.
- 21 October 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (12) , 2409-2411
Metastatic brachial plexopathy as the initial manifestation of breast cancer
Click on the article title to read more.
- 1 October 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (10) , 2056-2057
Unicentric castleman's disease of interpectoral (rotter's) lymph nodes mimicking a breast tumor
Click on the article title to read more.
- 1 October 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (10) , 2056-2057
Unicentric castleman's disease of interpectoral (rotter's) lymph nodes mimicking a breast tumor
Click on the article title to read more.
- Open Access
- 1 August 2020
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2020 (8) , rjaa271
Facing a dilemma in the treatment of an internal mammary artery mycotic pseudoaneurysm: coil embolization or surgery? A case report and brief literature review
While aneurysms of the internal mammary artery (IMA) complicate occasionally surgical procedures employing median sternotomy, or are associated with direct thoracic trauma, mycotic pseudoaneurysms of the vessel are rarely reported in the literature. We herein report a case of a 22-year-old man who developed a mycotic internal mammary artery pseudoaneurysm secondary to staphylococcal chest wall abscesses and was effectively treated by coil embolization. Additionally, the report provides a brief review focusing on the current state of treatment options for internal mammary artery aneurysms.
- 1 August 2020
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2020 (8) , rjaa271
Open AccessFacing a dilemma in the treatment of an internal mammary artery mycotic pseudoaneurysm: coil embolization or surgery? A case report and brief literature review
While aneurysms of the internal mammary artery (IMA) complicate occasionally surgical procedures employing median sternotomy, or are associated with direct thoracic trauma, mycotic pseudoaneurysms of the vessel are rarely reported in the literature. We herein report a case of a 22-year-old man who developed a mycotic internal mammary artery pseudoaneurysm secondary to staphylococcal chest wall abscesses and was effectively treated by coil embolization. Additionally, the report provides a brief review focusing on the current state of treatment options for internal mammary artery aneurysms.
- 29 May 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (9) , 1821-1822
Axillary silicone lymphadenopathy. An important differential in patients with post‐mastectomy reconstruction with silicone gel implants
- 29 May 2020
- Published by Hindawi Limited in The Breast Journal
- Vol. 26 (9) , 1821-1822
Axillary silicone lymphadenopathy. An important differential in patients with post‐mastectomy reconstruction with silicone gel implants